Newsroom

Felix Deschner in the lab
News
The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome these resistances, drugs with novel mode of action are urgently needed. Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have now uncovered the mode of action of a promising class of natural products – the chlorotonils. These molecules simultaneously target the bacterial cell membrane and the bacteria’s ability to produce proteins, enabling them to break through resistance. The team published its findings in the journal Cell Chemical Biology.
15.04.2025
Future Day
News
Today, around 60 schoolchildren from grades 5 to 9 visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig to gain an insight into the work of a modern research institution. They were able to immerse themselves in the fascinating world of science in a total of eight different departments.
03.04.2025
Group image
News
On March 17 and 18, 2025, the kick-off meeting of the INFRALINK network took place at the Helmholtz Centre for Infection Research (HZI) in Braunschweig. Six partner institutions will establish a network to facilitate infection research between the public health service and research institutions. The project is being funded by the Volkswagen Foundation with 500,000 euros.
02.04.2025
Josef Penninger
News
Science is currently facing major challenges in the United States – and with noticeable impacts on Europe. Research budgets have been and continue to be cut and jobs lost, even in key areas such as health and infectious diseases. A viewpoint from Josef Penninger, Scientific Director of the Helmholtz Centre for Infection Research.
01.04.2025
Electron microscope image
News
An international research group led by the Helmholtz Centre for Infection Research (HZI) has discovered a promising new drug candidate against severe lung infections caused by the hospital germ Staphylococcus aureus. The study, which has just been published in Cell Host & Microbe, describes for the first time how small molecules from the quinoxalinedione class specifically block the bacterial toxin α-hemolysin – a key trigger of tissue damage and inflammation.
01.04.2025
Florian Hubrich and Mariia Nesterkina
News
Acquiring external funding is an integral part of any young scientist’s path towards an independent research career. Such additional funds not only make their own scientific success visible, but also give them freedom to implement new and possibly riskier project ideas. One funding instrument that focuses on supporting early stage researchers is the Klaus-Tschira-Boost-Fund. In the current round of applications, 15 out of more than 300 applicants were selected to receive funding of up to 120,000 Euros each – amongst them the junior researchers Mariia Nesterkina and Florian Hubrich from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University. As so-called “Boost Fellows”, Mariia Nesterkina and Florian Hubrich benefit not only from the funding itself, but also from a series of workshops on career development and gain access to extensive career counseling and coaching services. The funded projects are set to start between April and October 2025 and will run for 24 months.
01.04.2025

HZI in the media

... haben. Ein Forschungsteam des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) in Würzburg hat in Zusammenarbeit ...

14.04.2026
|
PresseBox - DE

... der Infektion und Nozizeption“ am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig. Nozizeption ist der Fachbegriff ...

14.04.2026
|
Verband Deutscher Biologen e.V.

... recht nicht bei Fabian Leendertz, der in Greifswald das „Helmholtz-Institut für One Health“ leitet. Im ...

14.04.2026
|
FAZ.NET

... sich auch das Helmholtz-Institut für Pharmazeutische Forschung Saarland ( HIPS ), das Helmholtz-Zentrum für Infektionsforschung ( HZI ) ...

09.04.2026
|
Deutsches Ärzteblatt

... ÖAW in Wien und nun Gruppenleiter am Helmholtz Zentrum für Infektionsforschung in Braunschweig, forscht an ...

08.04.2026
|
DerStandard.de

... group within the Microstar Program at the Helmholtz Centre for Infection Research (HZI) and a ...

31.03.2026
|
Informations Dienst Wissenschaft

... an der Medizinischen Hochschule Hannover und am Helmholtz Institut für Infektionen in Braunschweig die Wirkung ...

28.03.2026
|
Hamburger Abendblatt

led by wildlife veterinarian Fabian Leendertz, who heads the Helmholtz Institute for One Health, took hundreds of samples from meat and

27.03.2026
|
Science.org

Gesellschaft. Apropos Standort Braunschweig: Auch das Helmholtz-Zentrum für Infektionsforschung HZI, in dessen Räumlichkeiten auf dem ...

27.03.2026
|
transkript

Helmholtz Centre for Infection Research

 

After infection with SARS-CoV-2, up to 10 percent of people in Germany go on to develop Long COVID.

26.03.2026
|
Mirage.News

... von verschiedenen Hörnchen, wie jüngste Erkenntnisse des Helmholtz Instituts für One Health in Greifswald kürzlich ...

26.03.2026
|
Tagesschau

zur Bekämpfung der Tuberkulose und des Helmholtz-Zentrums für Infektionsforschung erstellt. Zahlreiche weitere Fachgesellschaften und

24.03.2026
|
Deutsches Ärzteblatt

Register now for the HZI-Newsletter